| dc.contributor.author | Streinu-Cercel, Adrian | |
| dc.contributor.author | Seto, Wai Kay Walter | |
| dc.contributor.author | Buti, Maria | |
| dc.contributor.author | Izumi, Namiki | |
| dc.contributor.author | Lim, Young-Suk | |
| dc.contributor.author | Kao, Jia-Horng | |
| dc.contributor.author | Nurmukhametova, Elena | |
| dc.contributor.author | Ma, Xiaoli | |
| dc.contributor.author | Jablkowski, Maciej | |
| dc.contributor.author | Suri, Vithika | |
| dc.contributor.author | Flaherty, John F. | |
| dc.contributor.author | Lau, Audrey H. | |
| dc.contributor.author | Gaggar, Anuj | |
| dc.contributor.author | Mo, Shuyuan | |
| dc.contributor.author | Chowdhury, Abhijit | |
| dc.contributor.author | Fung, Scott K. | |
| dc.contributor.author | Chuang, Wan-Long | |
| dc.contributor.author | Gane, Edward J. | |
| dc.contributor.author | Tabak, Fehmi | |
| dc.date.accessioned | 2021-03-03T11:26:43Z | |
| dc.date.available | 2021-03-03T11:26:43Z | |
| dc.identifier.citation | Seto W. K. W. , Buti M., Izumi N., Lim Y., Kao J., Streinu-Cercel A., Nurmukhametova E., Ma X., Tabak F., Jablkowski M., et al., "Bone and Renal Safety Are Improved in Chronic HBV Patients 1 Year after Switching to Tenofovir Alafenamide (TAF) from Tenofovir Disoproxil Fumarate (TDF)", Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD) / Liver Meeting, San-Francisco, Kostarika, 9 - 13 Kasım 2018, cilt.68 | |
| dc.identifier.other | av_27f4adac-a4a4-4996-8113-ebbcb6582746 | |
| dc.identifier.other | vv_1032021 | |
| dc.identifier.uri | http://hdl.handle.net/20.500.12627/31717 | |
| dc.language.iso | eng | |
| dc.subject | İç Hastalıkları | |
| dc.subject | GASTROENTEROLOJİ VE HEPATOLOJİ | |
| dc.subject | Klinik Tıp | |
| dc.subject | Klinik Tıp (MED) | |
| dc.subject | Tıp | |
| dc.subject | Sağlık Bilimleri | |
| dc.subject | Dahili Tıp Bilimleri | |
| dc.subject | Gastroenteroloji-(Hepatoloji) | |
| dc.title | Bone and Renal Safety Are Improved in Chronic HBV Patients 1 Year after Switching to Tenofovir Alafenamide (TAF) from Tenofovir Disoproxil Fumarate (TDF) | |
| dc.type | Bildiri | |
| dc.contributor.department | University of Hong Kong , , | |
| dc.identifier.volume | 68 | |
| dc.contributor.firstauthorID | 155033 | |
